Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis

Juan F. Gallegos-Orozco, Catherine E. Yurk, Nulang Wang, Jorge Rakela, Michael R. Charlton, Garry R. Cutting, Vijayan Balan

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease of uncertain etiology. However, the histologic features of PSC liver disease can resemble those in cystic fibrosis (CF), an inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. We sought to determine if PSC patients have a higher frequency of common CF alleles than disease controls. METHODS: DNA was extracted from peripheral lymphocytes of patients with end-stage liver disease. Samples were obtained before liver transplantation from 59 PSC patients and from three groups of control patients (20 each with primary biliary cirrhosis, autoimmune hepatitis, or hepatitis C). DNA samples were genotyped for 32 common CF mutations, the intron 8 T tract variants, and the M470V variant. RESULTS: One of 59 PSC patients (1.7%) had the common CF mutation (ΔF508) in one CFTR gene. Two controls (3.3%) carried a single CF mutation (Δ508 in one primary biliary cirrhosis patient; W1282X in one hepatitis C patient). These rates do not differ from expected in the general population. The frequency of CFTR variants (5T and M470V) was also similar between PSC patients and controls. CONCLUSIONS: Despite anatomical similarities between CF liver disease and PSC, we could not confirm that PSC patients carried common CF mutations or common CFTR variants in higher than expected frequencies. These data suggest that CFTR dysfunction does not influence the pathogenesis of PSC.

Original languageEnglish (US)
Pages (from-to)874-878
Number of pages5
JournalAmerican Journal of Gastroenterology
Volume100
Issue number4
DOIs
StatePublished - Apr 2005

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Sclerosing Cholangitis
Regulator Genes
Cystic Fibrosis
Mutation
Liver Diseases
Biliary Liver Cirrhosis
Hepatitis C
Autoimmune Hepatitis
End Stage Liver Disease
DNA
Liver Transplantation
Introns
Alleles
Lymphocytes
Control Groups

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. / Gallegos-Orozco, Juan F.; Yurk, Catherine E.; Wang, Nulang; Rakela, Jorge; Charlton, Michael R.; Cutting, Garry R.; Balan, Vijayan.

In: American Journal of Gastroenterology, Vol. 100, No. 4, 04.2005, p. 874-878.

Research output: Contribution to journalArticle

Gallegos-Orozco, Juan F. ; Yurk, Catherine E. ; Wang, Nulang ; Rakela, Jorge ; Charlton, Michael R. ; Cutting, Garry R. ; Balan, Vijayan. / Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. In: American Journal of Gastroenterology. 2005 ; Vol. 100, No. 4. pp. 874-878.
@article{db17765747924e7fab373ddd27a7edac,
title = "Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis",
abstract = "BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease of uncertain etiology. However, the histologic features of PSC liver disease can resemble those in cystic fibrosis (CF), an inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. We sought to determine if PSC patients have a higher frequency of common CF alleles than disease controls. METHODS: DNA was extracted from peripheral lymphocytes of patients with end-stage liver disease. Samples were obtained before liver transplantation from 59 PSC patients and from three groups of control patients (20 each with primary biliary cirrhosis, autoimmune hepatitis, or hepatitis C). DNA samples were genotyped for 32 common CF mutations, the intron 8 T tract variants, and the M470V variant. RESULTS: One of 59 PSC patients (1.7{\%}) had the common CF mutation (ΔF508) in one CFTR gene. Two controls (3.3{\%}) carried a single CF mutation (Δ508 in one primary biliary cirrhosis patient; W1282X in one hepatitis C patient). These rates do not differ from expected in the general population. The frequency of CFTR variants (5T and M470V) was also similar between PSC patients and controls. CONCLUSIONS: Despite anatomical similarities between CF liver disease and PSC, we could not confirm that PSC patients carried common CF mutations or common CFTR variants in higher than expected frequencies. These data suggest that CFTR dysfunction does not influence the pathogenesis of PSC.",
author = "Gallegos-Orozco, {Juan F.} and Yurk, {Catherine E.} and Nulang Wang and Jorge Rakela and Charlton, {Michael R.} and Cutting, {Garry R.} and Vijayan Balan",
year = "2005",
month = "4",
doi = "10.1111/j.1572-0241.2005.41072.x",
language = "English (US)",
volume = "100",
pages = "874--878",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis

AU - Gallegos-Orozco, Juan F.

AU - Yurk, Catherine E.

AU - Wang, Nulang

AU - Rakela, Jorge

AU - Charlton, Michael R.

AU - Cutting, Garry R.

AU - Balan, Vijayan

PY - 2005/4

Y1 - 2005/4

N2 - BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease of uncertain etiology. However, the histologic features of PSC liver disease can resemble those in cystic fibrosis (CF), an inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. We sought to determine if PSC patients have a higher frequency of common CF alleles than disease controls. METHODS: DNA was extracted from peripheral lymphocytes of patients with end-stage liver disease. Samples were obtained before liver transplantation from 59 PSC patients and from three groups of control patients (20 each with primary biliary cirrhosis, autoimmune hepatitis, or hepatitis C). DNA samples were genotyped for 32 common CF mutations, the intron 8 T tract variants, and the M470V variant. RESULTS: One of 59 PSC patients (1.7%) had the common CF mutation (ΔF508) in one CFTR gene. Two controls (3.3%) carried a single CF mutation (Δ508 in one primary biliary cirrhosis patient; W1282X in one hepatitis C patient). These rates do not differ from expected in the general population. The frequency of CFTR variants (5T and M470V) was also similar between PSC patients and controls. CONCLUSIONS: Despite anatomical similarities between CF liver disease and PSC, we could not confirm that PSC patients carried common CF mutations or common CFTR variants in higher than expected frequencies. These data suggest that CFTR dysfunction does not influence the pathogenesis of PSC.

AB - BACKGROUND: Primary sclerosing cholangitis (PSC) is a chronic progressive cholestatic liver disease of uncertain etiology. However, the histologic features of PSC liver disease can resemble those in cystic fibrosis (CF), an inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. We sought to determine if PSC patients have a higher frequency of common CF alleles than disease controls. METHODS: DNA was extracted from peripheral lymphocytes of patients with end-stage liver disease. Samples were obtained before liver transplantation from 59 PSC patients and from three groups of control patients (20 each with primary biliary cirrhosis, autoimmune hepatitis, or hepatitis C). DNA samples were genotyped for 32 common CF mutations, the intron 8 T tract variants, and the M470V variant. RESULTS: One of 59 PSC patients (1.7%) had the common CF mutation (ΔF508) in one CFTR gene. Two controls (3.3%) carried a single CF mutation (Δ508 in one primary biliary cirrhosis patient; W1282X in one hepatitis C patient). These rates do not differ from expected in the general population. The frequency of CFTR variants (5T and M470V) was also similar between PSC patients and controls. CONCLUSIONS: Despite anatomical similarities between CF liver disease and PSC, we could not confirm that PSC patients carried common CF mutations or common CFTR variants in higher than expected frequencies. These data suggest that CFTR dysfunction does not influence the pathogenesis of PSC.

UR - http://www.scopus.com/inward/record.url?scp=17544373447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17544373447&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2005.41072.x

DO - 10.1111/j.1572-0241.2005.41072.x

M3 - Article

C2 - 15784035

AN - SCOPUS:17544373447

VL - 100

SP - 874

EP - 878

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 4

ER -